163 related articles for article (PubMed ID: 36600489)
1. Associations between the prevalence of chronic hepatitis B among people who inject drugs and country-level characteristics: An ecological analysis.
Syangbo A; Hickman M; Colledge-Frisby S; Leung J; Grebely J; Larney S; Degenhardt L; Trickey A
Drug Alcohol Rev; 2023 Mar; 42(3):569-581. PubMed ID: 36600489
[TBL] [Abstract][Full Text] [Related]
2. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review.
Degenhardt L; Peacock A; Colledge S; Leung J; Grebely J; Vickerman P; Stone J; Cunningham EB; Trickey A; Dumchev K; Lynskey M; Griffiths P; Mattick RP; Hickman M; Larney S
Lancet Glob Health; 2017 Dec; 5(12):e1192-e1207. PubMed ID: 29074409
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and risk factors associated with HIV/hepatitis B and HIV/hepatitis C co-infections among people who inject drugs in Mozambique.
Semá Baltazar C; Boothe M; Kellogg T; Ricardo P; Sathane I; Fazito E; Raymond HF; Temmerman M; Luchters S
BMC Public Health; 2020 Jun; 20(1):851. PubMed ID: 32493347
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of HIV, HCV and HBV infection and sociodemographic characteristics of people who inject drugs in China: A systematic review and meta-analysis.
Bao Y; Larney S; Peacock A; Colledge S; Grebely J; Hickman M; Degenhardt L; Leung J
Int J Drug Policy; 2019 Aug; 70():87-93. PubMed ID: 31125802
[TBL] [Abstract][Full Text] [Related]
5. A Global Meta-analysis of the Prevalence of HIV, Hepatitis C Virus, and Hepatitis B Virus Among People Who Inject Drugs-Do Gender-Based Differences Vary by Country-Level Indicators?
Leung J; Peacock A; Colledge S; Grebely J; Cunningham EB; Hickman M; Vickerman P; Stone J; Trickey A; Dumchev K; Lynskey M; Hines L; Griffiths P; Mattick RP; Degenhardt L; Larney S
J Infect Dis; 2019 Jun; 220(1):78-90. PubMed ID: 30726973
[TBL] [Abstract][Full Text] [Related]
6. Global prevalence of HCV and/or HBV coinfections among people who inject drugs and female sex workers who live with HIV/AIDS: a systematic review and meta-analysis.
Rashti R; Alavian SM; Moradi Y; Sharafi H; Mohamadi Bolbanabad A; Roshani D; Moradi G
Arch Virol; 2020 Sep; 165(9):1947-1958. PubMed ID: 32617764
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic review.
Degenhardt L; Webb P; Colledge-Frisby S; Ireland J; Wheeler A; Ottaviano S; Willing A; Kairouz A; Cunningham EB; Hajarizadeh B; Leung J; Tran LT; Price O; Peacock A; Vickerman P; Farrell M; Dore GJ; Hickman M; Grebely J
Lancet Glob Health; 2023 May; 11(5):e659-e672. PubMed ID: 36996857
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B/C in the countries of the EU/EEA: a systematic review of the prevalence among at-risk groups.
Falla AM; Hofstraat SHI; Duffell E; Hahné SJM; Tavoschi L; Veldhuijzen IK
BMC Infect Dis; 2018 Feb; 18(1):79. PubMed ID: 29433454
[TBL] [Abstract][Full Text] [Related]
9. Understanding hepatitis B, hepatitis C and HIV among people who inject drugs in South Africa: findings from a three-city cross-sectional survey.
Scheibe A; Young K; Moses L; Basson RL; Versfeld A; Spearman CW; Sonderup MW; Prabdial-Sing N; Manamela J; Puren AJ; Rebe K; Hausler H
Harm Reduct J; 2019 Apr; 16(1):28. PubMed ID: 30975139
[TBL] [Abstract][Full Text] [Related]
10. High prevalence of HIV, HBsAg and anti-HCV positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in Mozambique.
Semá Baltazar C; Horth R; Boothe M; Sathane I; Young P; Chitsondzo Langa D; Condula M; Ricardo H; Dengo Baloi L; Cummings B; Schaad N; Gouveia L; Teodoro E; Raymond HF
BMC Infect Dis; 2019 Dec; 19(1):1022. PubMed ID: 31791273
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus infection among people who use drugs in Iran: a systematic review, meta-analysis, and trend analysis.
Rostam-Abadi Y; Rafiemanesh H; Gholami J; Shadloo B; Amin-Esmaeili M; Rahimi-Movaghar A
Harm Reduct J; 2020 Oct; 17(1):81. PubMed ID: 33087141
[TBL] [Abstract][Full Text] [Related]
12. Incidence of HIV and hepatitis C virus among people who inject drugs, and associations with age and sex or gender: a global systematic review and meta-analysis.
Artenie A; Stone J; Fraser H; Stewart D; Arum C; Lim AG; McNaughton AL; Trickey A; Ward Z; Abramovitz D; Alary M; Astemborski J; Bruneau J; Clipman SJ; Coffin CS; Croxford S; DeBeck K; Emanuel E; Hayashi K; Hermez JG; Low-Beer D; Luhmann N; Macphail G; Maher L; Palmateer NE; Patel EU; Sacks-Davis R; Van Den Boom W; van Santen DK; Walker JG; Hickman M; Vickerman P;
Lancet Gastroenterol Hepatol; 2023 Jun; 8(6):533-552. PubMed ID: 36996853
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus, hepatitis C virus and human immunodeficiency virus infections among people who inject drugs in Kuwait: A cross-sectional study.
Altawalah H; Essa S; Ezzikouri S; Al-Nakib W
Sci Rep; 2019 Apr; 9(1):6292. PubMed ID: 31000775
[TBL] [Abstract][Full Text] [Related]
14. Socio-demographic and ecological factors associated with anti-HCV prevalence in people who inject drugs: A systematic review.
Colledge S; Leung J; Grebely J; Degenhardt L; Peacock A; Hickman M; Vickerman P; Stone J; Trickey A; Larney S
Drug Alcohol Depend; 2020 Apr; 209():107899. PubMed ID: 32086179
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of HIV and other infections and injection behaviours among people who inject drugs in Addis Ababa, Ethiopia.
Demissie M; Johnston LG; Muleta M; Desyebelew D; Belete W; G/Egxiabehre A; Gezahegn N; Kassa D; Aseffa Y
Afr J AIDS Res; 2018 Sep; 17(3):259-264. PubMed ID: 30319040
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B and C Virus Infections Among Human Immunodeficiency Virus-Infected People Who Inject Drugs in Lahore, Pakistan.
Mansha S; Imran M; Shah AMUH; Jamal M; Ahmed F; Atif M; Saleem M; Safi SZ; Fatima Z; Bilal Waqar A
Viral Immunol; 2017 Jun; 30(5):366-370. PubMed ID: 28346804
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of and risk factors for HBV and HCV among incarcerated people who inject drugs in Iran: A cross sectional study.
Moradi G; Mohamadi P; Zareie B; Rasouli MA; Gouya MM; Jafari S
BMC Infect Dis; 2020 Oct; 20(1):806. PubMed ID: 33129259
[TBL] [Abstract][Full Text] [Related]
18. Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis.
Stone J; Fraser H; Lim AG; Walker JG; Ward Z; MacGregor L; Trickey A; Abbott S; Strathdee SA; Abramovitz D; Maher L; Iversen J; Bruneau J; Zang G; Garfein RS; Yen YF; Azim T; Mehta SH; Milloy MJ; Hellard ME; Sacks-Davis R; Dietze PM; Aitken C; Aladashvili M; Tsertsvadze T; Mravčík V; Alary M; Roy E; Smyrnov P; Sazonova Y; Young AM; Havens JR; Hope VD; Desai M; Heinsbroek E; Hutchinson SJ; Palmateer NE; McAuley A; Platt L; Martin NK; Altice FL; Hickman M; Vickerman P
Lancet Infect Dis; 2018 Dec; 18(12):1397-1409. PubMed ID: 30385157
[TBL] [Abstract][Full Text] [Related]
19. A large proportion of people who inject drugs are susceptible to hepatitis B: Results from a bio-behavioural study in eight German cities.
Haussig JM; Nielsen S; Gassowski M; Bremer V; Marcus U; Wenz B; Bannert N; Bock CT; Zimmermann R;
Int J Infect Dis; 2018 Jan; 66():5-13. PubMed ID: 29097248
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of injecting drug use and HIV, hepatitis B, and hepatitis C in people who inject drugs in the Eastern Mediterranean region: a systematic review and meta-analysis.
Aghaei AM; Gholami J; Sangchooli A; Rostam-Abadi Y; Olamazadeh S; Ardeshir M; Baheshmat S; Shadloo B; Taj M; Saeed K; Rahimi-Movaghar A
Lancet Glob Health; 2023 Aug; 11(8):e1225-e1237. PubMed ID: 37474230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
